Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy

Effects Of Kabat Rehabilitation Versus Mime Therapy On Facial Disability And Synkinesis In Patients Of Bell's Palsy

Bell's palsy, also called idiopathic facial paralysis, is a common cause of unilateral facial paralysis. It is one of the most common neurological disorders of the cranial nerves.

Study Overview

• Status: Recruiting
• Conditions: Bell Palsy
• Intervention / Treatment: Other: Kabat Therapy; Other: Mime Therapy

Detailed Description

Bell's palsy is an alarming condition of rapid onset, which paralyzes half of the facial muscles. Kabat rehabilitation is a manual resistance technique that promotes a basic pattern of movement through facilitation, inhibition, and resistance of a group of muscles. It increases the functioning and power of facial muscles while Mime therapy results in immediate improvement of function and integrity of facial muscles. It also mitigates synkinesis in Bell's palsy. Both techniques are easy to apply. They are clinically important techniques that are easily understood by patients.

• Study Type: Interventional
• Enrollment (Estimated): 85
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ayesha Jamil, M.Phil; Phone Number: +923244481031; Email: ayeshabutt031@gmail.com
• Study Contact Backup: Name: Ayesha Amjad, MS; Phone Number: +923054645864; Email: ayeshaamjad056@gmail.com

Study Locations

• Pakistan
  • Punjab
    • Lahore, Punjab, Pakistan, 5400
      • Recruiting
      • The University of Lahore
      • Contact: Ayesha Jamil, M.Phil; Phone Number: +923244481031; Email: ayesha.jamil@uipt.uol.edu.pk
      • Contact: Ayesha Amjad, MS; Phone Number: +923054645864; Email: ayeshaamjad056@gmail.com
      • Principal Investigator: Ayesha Amjad, MS

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Age group 25-50 years.
2. Both male and female.
3. Unilateral bell's paralysis.
4. Not congenital in origin.
5. Sub-acute and chronic cases.

Exclusion Criteria:

1. Other neurological deficits include epilepsy and Alzheimer's disease.
2. Traumatic onset.
3. Surgical reconstruction (nerve or muscle reconstruction).
4. Mental and psychological disorders i.e., schizophrenia, bipolar disorders.
5. Skin diseases (eczema, urticarial) as electrical stimulation may affect the results.
6. Any contraindications for massage like sunburn, bruising, or cuts.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Kabat Therapy; Kabat exercises primarily assist functional response in defective muscles through the general structure of muscles experiencing resistance. After 6th week, resting and voluntary symmetries were recorded.	Other: Kabat Therapy; The participants of group A will receive Kabat Rehabilitation with routine physical therapy. The protocol will be given to the participants for three sessions/week for six weeks. Each session will be of 30 minutes.
Experimental: Mime Therapy; Mime therapy utilizes emotional input to access better movement patterns. It is beneficial as it improves circulation and maintains muscle properties.	Other: Mime Therapy; The participants of group B will receive Mime Therapy in addition to routine physical therapy. The protocol will be given to the participants once a week for six weeks, while physical therapy will be given on alternate days. Each session will be of 30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Synkinesis	Synkinesis will be accessed through the "House-Brackmann Scale". It is classified as a universal scale. This scale analyses the symmetry, synkinesis, stiffness, and global mobility of the face. It is divided into six categories (normal, mild dysfunction, moderate dysfunction, moderately severe dysfunction, severe dysfunction, and total paralysis) and is a 0-6-point scale with 6 representing total paralysis.	It will be assessed at baseline, at the third week and at six week.
Level of Facial Disability	The level of Facial disability will be measured through the "Facial Disability Index Scale". This scale has ten items that evaluate the patient's physical and social aspects (mastication, deglutition, communication, labial mobility, emotional alterations, and social integration). It uses a hundred-point scale with a higher score indicating less impairment. 24 Minimum score for physical functioning: 0, Maximum score for physical functioning: 25, Minimum score for social and well-being: 5, Maximum score for social and well-being.	Change in functional status will be measured at the baseline, at 3rd week and at 6th week.

Collaborators and Investigators

• Sponsor: University of Lahore
• Investigators: Study Chair: Ashfaq Dr Ahmed, PhD, The University of Lahore

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2023
• Primary Completion (Estimated): September 30, 2023
• Study Completion (Estimated): October 15, 2023

Study Registration Dates

• First Submitted: September 1, 2023
• First Submitted That Met QC Criteria: September 1, 2023
• First Posted (Actual): September 8, 2023

Study Record Updates

• Last Update Posted (Actual): September 13, 2023
• Last Update Submitted That Met QC Criteria: September 12, 2023
• Last Verified: September 1, 2023

More Information

Terms related to this study

• Keywords: Bell Palsy; Kabat Rehabilitation; Mime Therapy
• Additional Relevant MeSH Terms: Nervous System Diseases; Virus Diseases; Infections; Neurologic Manifestations; Stomatognathic Diseases; Mouth Diseases; DNA Virus Infections; Dyskinesias; Cranial Nerve Diseases; Herpesviridae Infections; Facial Nerve Diseases; Paralysis; Bell Palsy; Facial Paralysis; Synkinesis
• Other Study ID Numbers: REC-UOL-406-05-2023

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Sharing Time Frame: Immediately after publication
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No